COVID-19 Poses Greater Risk to Hospitalized Patients
People with Parkinson’s disease who are hospitalized with COVID-19Â may have a greater risk for more severe infections and…
Articles by Forest Ray PhD
Korean Study Ties Air Pollution to Developing Parkinson’s
Nitrogen dioxide (NO2) is associated significantly with a higher risk for developing Parkinson’s disease, according to a recent study…
Ketamine Advances as Treatment for Levodopa-induced Dyskinesia
The U.S. Food and Drug Administration (FDA) has approved PharmaTher‘s investigational new drug (IND) application for ketamine as…
Anxiety May Be Unique for Each Patient
Anxiety appears to worsen the physical and cognitive symptoms of Parkinson’s disease, despite the various ways that individuals experience…
Partnership Seeks to Develop New Therapies
Alligator Bioscience and BioArctic AB have partnered to research and develop new therapies for neurodegenerative disorders such as…
ROPAD Study of Parkinson’s Genetics Enrolling 2,500 More Patients
Centogene announced plans to recruit 2,500 more patients this year into its observational Rostock International Parkinson’s Disease (ROPAD) study…
New ‘NeuroInsight’ Fellowship Program Awarded €4.7M
A new research training program called NeuroInsight is seeking to teach scientists in the data analytics and neuroscience skills needed…
Changes in Nerve Network of Brain May Cause Presence Hallucinations
Disruptions in a network of interconnected nerves in the brain appear to underlie what are known as perception hallucinations in people…
Neuroticism May be Parkinson’s Risk Factor
The personality trait neuroticism correlates with a higher risk of developing Parkinson’s disease, according to recent research. The study,…
Phase 2 Trial of Stem Cell Therapy in Parkinson’s Patients Enrolling
A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially disease-modifying treatment for Parkinson’s, building…